St. Louis University

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, St. Louis University sits in the top decile of US sponsors by registered trial count (#228 of 15,742 sponsors by registered trial count).

107 total trials 12 currently recruiting 63 completed top decile by trial count

St. Louis University: 107 sponsored US clinical trials, 12 recruiting.

St. Louis University sponsors 107 registered US clinical trials on ClinicalTrials.gov, 12 of them currently recruiting, and 63 completed. 12 of these trials are in Phase 3-4 (later-stage) and 12 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Opioid Use, with 3 trials.

Top-decile sponsor footprint

St. Louis University ranks in the top decile of sponsors by registered trial count (#228 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 14/100

63 of 90 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (70.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

107 total, page 2 of 3

TERMINATED

Psychosocial Factors of Burn Related Injuries and Perceived Gaps in Service Delivery

NCT03094013

TERMINATED Phase 4

NSAID Use in Postpartum Hypertensive Women

NCT02902172

COMPLETED NA

Noninferiority Trial of Liquid Human Milk Fortifier (HMF) Hydrolyzed Protein Versus Liquid HMF With Supplemental Liquid Protein

NCT03001479

TERMINATED NA

Hemodynamic Effects of Blood Flow Variation in Continuous Renal Replacement Therapy

NCT03078504

COMPLETED NA

PFA-100 Responsive to Effect of Energy Drinks on Platelet Function

NCT02997111

COMPLETED

High Tone Pelvic Floor Dysfunction

NCT03083262

COMPLETED

Platelet Activating Factor Stability in Urine

NCT03103477

COMPLETED

Effect of Patient Resilience on Return to Sport Post ACL Reconstruction Surgery

NCT03013231

TERMINATED NA

Cerclage for Short Cervix in Twins

NCT02912390

COMPLETED

Repeat Antenatal Corticosteroids

NCT03133104

COMPLETED NA

Interventional Study to Evaluate the Appearance of Surgical Scars After Laser Therapy

NCT02985151

COMPLETED NA

Characteristics of Patient Population With Endometriosis

NCT03002870

COMPLETED

Central Arterial Pressure Changes With Use of Regional Anesthesia in Obstetric Patients

NCT02933541

COMPLETED

Activation of the Sphingosine-1-phosphate (S1P) to S1P1 Receptor Subtype (S1PR1) Axis in Patients With Endometriosis: Identification of Potential Relevant Biomarkers to Diagnose and Treat

NCT02973854

COMPLETED NA

Early Weight Bearing on Supracondylar Distal Femur Fractures in Elderly Patients

NCT02475941

COMPLETED NA

Text4Peds: Short Message Service Evaluating Medical Student Education

NCT03346616

COMPLETED

The Correlation of Women's Sexual Health and Marijuana Use

NCT02865096

COMPLETED NA

Patterns and Prevalence of FDG Extravasation in PET/CT Scans

NCT03041090

COMPLETED NA

SmartMouth Advanced Clinical Formula Clinical Research Design Protocol

NCT02709785

COMPLETED NA

Evaluation of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With Decompensated Cirrhosis With Ascites

NCT02608658

COMPLETED

Assessment of Immediate Adverse Reactions From Dotarem in Children Under 2 Years of Age

NCT02609919

COMPLETED

Genetic and Blood Biomarkers in Neurological and Neuromuscular Diseases

NCT02780531

TERMINATED

Noninvasive Prenatal Testing

NCT02586428

TERMINATED NA

Cervical Ripening in Postmenopausal Women

NCT02534883

COMPLETED Early Phase 1

SSRIs vs. TCAs for Depression in ALS Patients

NCT02851914

TERMINATED NA

Fetal Myelomeningocele Repair With Maternal BMI Between 35.0 and 40.0

NCT02509377

TERMINATED

Interstitial Cystitis (IC)-Like Findings With Hydrodistension

NCT02547298

COMPLETED

Shear Wave Sonoelastography in Pediatric Liver Fibrosis

NCT02372682

COMPLETED Phase 2

Neoadjuvant Pembrolizumab for Unresectable Stage III and Unresectable Stage IV Melanoma

NCT02306850

COMPLETED NA

Balloon Catheter for Cervical Ripening

NCT02606643

TERMINATED NA

Trial of Nortriptyline and Topiramate in the Initial Treatment of Vestibular Migraine

NCT02169830

COMPLETED NA

Primary Care Stepping Stones Triple P for Children With Autism

NCT02236650

TERMINATED NA

Cosmetic Outcome at 4 Months in Hand and Feet Lacerations in Children: Conservative Versus Suture Repair

NCT03321721

COMPLETED

The Monica Fetal Heart Monitor

NCT02546011

TERMINATED Phase 2

Fosaprepitant for N/V With High-dose Interleukin-2 for Metastatic Melanoma and Renal Cell Carcinoma

NCT01874119

TERMINATED NA

Evaluation of Hysterotomy Site After Open Fetal Surgery

NCT02493062

COMPLETED NA

Exercise: Addressing Stress in Relapse Prevention for Substance Use Disorders

NCT01828307

TERMINATED

Comparison of RightSpot pH Indicator & RightLevel pH Detector With X-Ray Verification for FT or G-Tube Placement

NCT01825564

COMPLETED NA

Self-Retaining Retractor in Obese Patients Undergoing Cesarean Section

NCT01826604

TERMINATED Phase 4

Exploring the Use of Transdermal Methylphenidate to Reduce Fall Risk in Patients With Dementia.

NCT01825577

COMPLETED NA

Milking the Umbilical Cord for Extreme Preterm Infants

NCT01666847

COMPLETED NA

Lifestyle Intervention Forever: Healthy Weight for Pregnancy and Birth (Pilot Study)

NCT01693666

COMPLETED NA

A Cost Effective Treatment for Headache in Pregnancy When Acetaminophen Alone is Ineffective.

NCT02295280

COMPLETED NA

Disposable Energy Sources and Operating Room Time for Laparoscopic Hysterectomy

NCT02065453

COMPLETED

Packed Red Blood Cell Transfusion and Intestinal Blood Flow in Preterm Neonates

NCT01628133

TERMINATED Phase 1

Subcutaneous Ig Maintenance Therapy for Myasthenia Gravis

NCT01828294

TERMINATED Phase 4

rhBMP-2 Versus Autograft in Critical Size Tibial Defects

NCT00853489

COMPLETED Phase 1

Exercise as Alcohol Use Disorders Intervention for Non-Treatment Seeking Adults

NCT01399554

COMPLETED

Early Detection of Autism Spectrum Disorder in Children

NCT01646866

COMPLETED NA

Seborrheic Dermatitis: Ketoconazole 2% Foam Versus Ketoconazole 2% Shampoo

NCT01203189

← Previous Page 2 of 3 Next →

What is open in the St. Louis University pipeline

12 recruiting of 107 indexed (11% open); 63 completed (59%).

Phase mix: 12 late (III/IV) vs 12 early (I/II) (balanced across stages).

Top condition: Opioid Use (3 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

St. Louis University: open-pipeline peers nationwide

Peers matched on 107 registered trials and 11% open enrollment, not the therapeutic-area sidebar.

St. Louis University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 050100150200 5%10%15%20% Total trials Recruiting share St. Louis UniversityGeisinger ClinicUniversity of ConnecticutNemours Children's ClinicAugusta UniversityAstellas Pharma Global DevelopmentADC Therapeutics S.A.Adrian VellaAIDS Malignancy Consortium
St. Louis University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

St. Louis University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 107 trials (± recruiting share)

Sponsors near 11% open enrollment (± trial volume)

What to do with this St. Louis University page

107 registered trials is a research-attention snapshot, not an endorsement of St. Louis University or any single study.

  • 12 of St. Louis University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Opioid Use is the condition St. Louis University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Opioid Use trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. St. Louis University pipeline card: 107 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.